Warning This website requires JavaScript to function correctly. Please enable JavaScript in your web browser settings or white-list our domain "www.bbisolutions.com" if you use any plug-ins to block JavaScript.

Blogs

13.06.2022 • Blogs

7 Mins

Increased demand in Antiphospholipid Syndrome markers?

Can APS markers predict the occurence of thrombosis in COVID-19 patients? Can APS markers predict the occurence of thrombosis in COVID-19 patients? Read our blogpost to find out more.

28.10.2021 • Blogs

4 Mins

Sexually transmitted Infections have decreased, but is going digital the future for diagnosis?

Lockdown consequences: Sexually Transmitted Infections have decreased, but is going digital the future for diagnosis? As much of the world spent huge parts of 2020 ...

17.06.2021 • Blogs

3 Mins

Why choose a human chimeric antibody over disease state plasma as a control?

Establishing the need As an assay developer will know, the detection of antibodies in patient samples requires reference material to determine cut-off values and test assay integrity. Most often this ...

26.10.2020 • Blogs

6 Mins

Facilitating Fast Action to Tackle Legionella Risk with Hydrosense Ltd

Novarum™ has created a bespoke mobile app-based test reader and customisable data storage system solution for the world's first and fastest on-site Legionella test. Novarum's custom-buil...

BBI Solutions Brands

DIARECT has a world leading recombinant autoimmune antigen capability immediately that enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier.

Maine Biotechnology Services brings 28 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application.

Novarum™ technology transforms a smartphone into a diagnostic test reader and work flow management system , empowering users to read and share the results of rapid tests at the point of care connecting patients and doctors, field workers, lab researchers and primary care clinicians to specialist practices as part of a mobile eco-system.

BioTeZ Berlin-Buch GmbH is a biotechnology company founded in 1992. BioTeZ is a partner of research institutions, the pharmaceutical industry and laboratory diagnostics.

STEFFENS BIOTECHNISCHE ANALYSEN GmbH has been developing and producing Enzyme-Linked Immuno Sorbent Assay (ELISA) test kits and components since 1991, both as an OEM manufacturer and for direct sales.

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox